COYA THERAPEUTICS INC (COYA) Stock Earnings & Estimates
NASDAQ:COYA - US22407B1089 - Common Stock
6.57 USD
-0.14 (-2.09%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.002M | 3.554M -40.79% | 2.953M -16.91% | 994.5K -66.32% | 8.5M 754.70% | 12.75M 50.00% | 15.645M 22.71% | 44.121M 182.01% | 264.71M 499.96% | 458.84M 73.34% | ||
| EBITDA YoY % growth | -9.78M -101.65% | -7.333M 25.02% | -17.197M -134.53% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.81M -101.44% | -7.36M 24.97% | -17.225M -134.02% | -27.148M -57.61% | -34.63M -27.56% | -24.693M 28.69% | -45.928M -85.99% | -51.028M -11.10% | -53.578M -5.00% | 217.09M 505.19% | 403.64M 85.93% | |
| Operating Margin | N/A | -122.63% | -484.64% | -919.34% | -3,482.14% | -290.51% | -360.22% | -326.16% | -121.43% | 82.01% | 87.97% | |
| EPS YoY % growth | N/A | -0.79 57.44% | -0.97 -22.78% | -1.55 -59.84% | -1.92 -23.68% | -1.61 15.96% | -0.21 86.71% | -0.11 47.62% | 2.02 1,900.00% | 8.15 303.54% | 14.27 75.09% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.29 -9.85% | -0.48 -180.28% | -0.53 -20.55% | -0.51 -42.23% | -0.54 -89.29% | -0.43 9.02% |
| Revenue Q2Q % growth | 3.689M | 224.4K 11,407.69% | 374.003K 44.96% | 374.003K 128.05% | 459K -87.56% | 459K 104.55% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.535M -1.90% | -8.483M -107.91% | -8.739M -13.83% | -7.908M -23.28% | -8.093M -78.45% | -8.094M 4.59% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.36 -89.47% | -0.40 | 0.04 | 10.16% |
| Q1 2025 Q2Q % growth | -0.44 -25.71% | -0.20 | -0.24 | -121.22% |
| Q4 2024 Q2Q % growth | -0.17 -160.71% | -0.27 | 0.10 | 37.11% |
| Q3 2024 Q2Q % growth | -0.26 45.83% | -0.42 | 0.16 | 38.58% |
| Q2 2024 Q2Q % growth | -0.19 38.71% | -0.14 | -0.05 | -33.05% |
| Q1 2024 Q2Q % growth | -0.35 -25.00% | -0.31 | -0.04 | -14.38% |
| Q4 2023 Q2Q % growth | 0.28 | 0.27 | 0.01 | 5.58% |
| Q3 2023 Q2Q % growth | -0.48 | -0.38 | -0.10 | -27.19% |
| Q2 2023 Q2Q % growth | -0.31 | -0.33 | 0.02 | 5.02% |
| Q1 2023 Q2Q % growth | -0.28 | -0.44 | 0.16 | 36.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 164K -95.21% | 798.997K | -634.997K | -79.47% |
| Q1 2025 Q2Q % growth | 258K 103.15% | 2.686M | -2.428M | -90.39% |
| Q4 2024 Q2Q % growth | 1.95K -99.97% | 68.003K | -66.053K | -97.13% |
| Q3 2024 Q2Q % growth | 178.5K | -178.5K | -100.00% | |
| Q2 2024 Q2Q % growth | 3.425M | 3.978M | -552.73K | -13.89% |
| Q4 2023 Q2Q % growth | 6.002M | 7.65M | -1.648M | -21.54% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.03% | -13.51% | 1.84% | -50.49% |
| Revenue | -1.81% | 703.7% | -31.61% | -57.27% |